KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medpace Holdings (MEDP) Profit After Tax (2016 - 2026)

Medpace Holdings filings provide 12 years of Profit After Tax readings, the most recent being $123.9 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 8.09% to $123.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $460.4 million, a 10.57% increase, with the full-year FY2025 number at $451.1 million, up 11.56% from a year prior.
  • Profit After Tax hit $123.9 million in Q1 2026 for Medpace Holdings, down from $135.1 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $135.1 million in Q4 2025 to a low of $49.4 million in Q2 2022.
  • Median Profit After Tax over the past 5 years was $88.4 million (2024), compared with a mean of $88.7 million.
  • Biggest five-year swings in Profit After Tax: skyrocketed 49.45% in 2024 and later increased 2.16% in 2025.
  • Medpace Holdings' Profit After Tax stood at $68.7 million in 2022, then increased by 14.02% to $78.3 million in 2023, then skyrocketed by 49.45% to $117.0 million in 2024, then grew by 15.48% to $135.1 million in 2025, then fell by 8.33% to $123.9 million in 2026.
  • The last three reported values for Profit After Tax were $123.9 million (Q1 2026), $135.1 million (Q4 2025), and $111.1 million (Q3 2025) per Business Quant data.